STAPLETON RAYMOND D JR 4
4 · GENOCEA BIOSCIENCES, INC. · Filed Mar 17, 2021
Insider Transaction Report
Form 4
STAPLETON RAYMOND D JR
EVP PHARM SCI & MFG
Transactions
- Award
Restricted Stock Unit
2021-03-15+100,000→ 100,000 total→ Common Stock (100,000 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents the right to receive, at settlement, one share of common stock.
- [F2]Vesting of these restricted stock units depends on the average closing price of a share of Genocea Biosciences, Inc.'s common stock over the sixty trading days immediately preceding December 31, 2023. The"target" number of restricted stock units is reported. Between 75% and 150% of the target number of units may vest on December 31, 2023, with the vesting percentage determined based on actual performance.